FR2427333B1 - - Google Patents

Info

Publication number
FR2427333B1
FR2427333B1 FR7914164A FR7914164A FR2427333B1 FR 2427333 B1 FR2427333 B1 FR 2427333B1 FR 7914164 A FR7914164 A FR 7914164A FR 7914164 A FR7914164 A FR 7914164A FR 2427333 B1 FR2427333 B1 FR 2427333B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7914164A
Other versions
FR2427333A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2427333A1 publication Critical patent/FR2427333A1/fr
Application granted granted Critical
Publication of FR2427333B1 publication Critical patent/FR2427333B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7914164A 1978-06-02 1979-06-01 Nouveaux aminothiazoles et composition pharmaceutique les contenant Granted FR2427333A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (2)

Publication Number Publication Date
FR2427333A1 FR2427333A1 (fr) 1979-12-28
FR2427333B1 true FR2427333B1 (fr) 1983-05-20

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7914164A Granted FR2427333A1 (fr) 1978-06-02 1979-06-01 Nouveaux aminothiazoles et composition pharmaceutique les contenant

Country Status (36)

Country Link
JP (1) JPS5936988B2 (fr)
AR (1) AR226285A1 (fr)
AT (1) AT373248B (fr)
AU (1) AU511242B2 (fr)
BE (1) BE876732A (fr)
CA (1) CA1117949A (fr)
CH (1) CH639653A5 (fr)
CS (1) CS216927B2 (fr)
DD (1) DD144055A5 (fr)
DE (1) DE2922523C2 (fr)
DK (1) DK150068C (fr)
EG (1) EG14354A (fr)
ES (1) ES481220A1 (fr)
FI (1) FI68820C (fr)
FR (1) FR2427333A1 (fr)
GB (1) GB2022085B (fr)
GR (1) GR73142B (fr)
HK (1) HK66487A (fr)
HU (1) HU180045B (fr)
IE (1) IE48426B1 (fr)
IL (1) IL57450A (fr)
IT (1) IT1121238B (fr)
KE (1) KE3459A (fr)
LU (1) LU81349A1 (fr)
MY (1) MY8500318A (fr)
NL (1) NL178421C (fr)
NO (1) NO150760C (fr)
NZ (1) NZ190623A (fr)
PH (1) PH17020A (fr)
PL (1) PL117515B1 (fr)
PT (1) PT69718A (fr)
SE (1) SE438333B (fr)
SG (1) SG56184G (fr)
SU (1) SU843746A3 (fr)
YU (1) YU40997B (fr)
ZA (1) ZA792729B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001481A1 (fr) * 1980-10-24 1982-05-13 Ronald P Hansen Systeme de reduction de la poussiere
EP0068033B1 (fr) * 1981-01-08 1985-07-10 Mitsui Toatsu Kagaku Kabushiki Kaisha Derives de n-(4-phenyl-2-thiazolyl)carbamate, procede de preparation et composition medicinale les contenant
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
WO1982002386A1 (fr) * 1981-01-13 1982-07-22 Sakano Isao Derives d'aminothiazoles, procede de preparation et composition medicinale les contenant
EP0069154B1 (fr) * 1981-01-13 1986-10-15 Mitsui Toatsu Kagaku Kabushiki Kaisha Nouveaux composes de thiazole, procede de preparation, et composition medicinale en contenant
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
DE69031624T2 (de) * 1989-08-10 1998-05-14 Commw Scient Ind Res Org Verfahren zur herstellung von einer elektrosuspension von mikropartikeln
WO1992015570A1 (fr) * 1991-03-07 1992-09-17 Hisamitsu Pharmaceutical Co., Inc. Nouveau derive de diphenylthiazole
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー 炎症処置用の置換チアゾール化合物
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
WO2001064674A1 (fr) 2000-03-01 2001-09-07 Janssen Pharmaceutica N.V. Derives de thiazolyle 2,4-disubstitue
WO2003015777A1 (fr) * 2001-08-13 2003-02-27 Lion Bioscience Ag Composes de liaison au recepteur nucleaire nr1h4
AU2002362603A1 (en) * 2001-09-26 2003-04-07 Bayer Corporation 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
WO2003059880A1 (fr) 2002-01-11 2003-07-24 Sankyo Company, Limited Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
EP1555264A1 (fr) * 2004-01-15 2005-07-20 Sireen AG Hétérocycles à cinq chaínons comme inhibiteurs de la famille des SRC proteines kinases
CN1921847B (zh) 2004-02-24 2010-06-16 三共株式会社 氨基醇化合物
SG159561A1 (en) * 2005-05-09 2010-03-30 Achillion Pharmaceuticals Inc Thiazole compounds and methods of use
US7514566B2 (en) 2006-01-18 2009-04-07 Amgen, Inc. Thiazole compounds and methods of use
AU2008276512A1 (en) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of PKB
JP2010533715A (ja) 2007-07-17 2010-10-28 アムジエン・インコーポレーテツド 複素環系ｐｋｂ調節剤
US20130143927A1 (en) * 2011-06-10 2013-06-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2012170931A2 (fr) 2011-06-10 2012-12-13 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
US9856240B2 (en) 2011-10-19 2018-01-02 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
DD144055A5 (de) 1980-09-24
IE791069L (en) 1979-12-02
NZ190623A (en) 1984-07-06
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
PL216030A1 (fr) 1980-03-10
NO150760B (no) 1984-09-03
JPS5936988B2 (ja) 1984-09-06
DE2922523C2 (de) 1982-10-21
IT1121238B (it) 1986-03-26
IL57450A0 (en) 1979-09-30
JPS54160369A (en) 1979-12-19
IE48426B1 (en) 1985-01-23
NL7904337A (nl) 1979-12-04
FI68820C (fi) 1985-11-11
SE7904798L (sv) 1979-12-03
SG56184G (en) 1985-03-08
AT373248B (de) 1983-12-27
AU511242B2 (en) 1980-08-07
BE876732A (fr) 1979-12-03
GB2022085B (en) 1983-01-12
AU4763479A (en) 1979-12-06
KE3459A (en) 1984-10-12
ES481220A1 (es) 1980-09-01
GB2022085A (en) 1979-12-12
HK66487A (en) 1987-09-25
NO150760C (no) 1984-12-12
IT7923228A0 (it) 1979-06-01
FI791754A (fi) 1979-11-26
IL57450A (en) 1982-11-30
NL178421C (nl) 1986-03-17
HU180045B (en) 1983-01-28
DK150068C (da) 1987-06-29
NL178421B (nl) 1985-10-16
LU81349A1 (fr) 1979-12-07
NO791831L (no) 1979-12-04
FR2427333A1 (fr) 1979-12-28
DK150068B (da) 1986-12-01
SU843746A3 (ru) 1981-06-30
DK177679A (da) 1979-12-03
CA1117949A (fr) 1982-02-09
SE438333B (sv) 1985-04-15
YU128879A (en) 1982-10-31
CS216927B2 (en) 1982-12-31
DE2922523A1 (de) 1979-12-06
EG14354A (en) 1984-06-30
AR226285A1 (es) 1982-06-30
FI68820B (fi) 1985-07-31
YU40997B (en) 1986-10-31
GR73142B (fr) 1984-02-09
ZA792729B (en) 1981-03-25
MY8500318A (en) 1985-12-31
ATA401679A (de) 1983-05-15
PH17020A (en) 1984-05-11
CH639653A5 (fr) 1983-11-30

Similar Documents

Publication Publication Date Title
FR2427333B1 (fr)
DK147399A (fr)
FR2414877B1 (fr)
FR2414663B3 (fr)
FR2414694B2 (fr)
FR2415359B1 (fr)
AU3898778A (fr)
AU3803078A (fr)
AU3892778A (fr)
AU73950S (fr)
BG26007A1 (fr)
BE871570A (fr)
BG25922A1 (fr)
BG25921A1 (fr)
BG25918A1 (fr)
BG25917A1 (fr)
BG25902A1 (fr)
BG25952A1 (fr)
BG25954A1 (fr)
BG25898A1 (fr)
BG25955A1 (fr)
BG25897A1 (fr)
BG25956A1 (fr)
BG25957A1 (fr)
BG26008A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse